Comparative bioavailability of two capsule formulations of mefenamic acid

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 8, 1997, Pages 329-333

  Rawashdeh, N M ^a   Najib, N M ^b   Jalal, I M ^c  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c HIKMA PHARMACEUTICALS   (Jordan)

Author keywords

Antiinflammatory drugs; Bioequivalence; Comparative bioavailability; Fendol; Mefenamic acid; Pharmacokinetic; Ponstan

Indexed keywords

MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; ULTRAVIOLET SPECTROSCOPY;

ADULT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DICLOFENAC; HUMANS; MALE; MEFENAMIC ACID; REGRESSION ANALYSIS; THERAPEUTIC EQUIVALENCY; TIME FACTORS;

EID: 0030759802     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Balton S 1990 Pharmaceutical statistics, practical and clinical applications. Dekker, New York, pp 162, 195
2. Chamberlain G 1992 Comparing treatment for menorrhagia. Nurs Times 88: 46
3. Diletti E, Hauschke D, Steinijans VW 1991 Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Pharmacol Ther Toxicol 29: 1-8
4. Galle PC, Mcrae MA 1993 Abnormal uterine bleeding. Finding and treating the cause. Postgrad Med (US) 93:73-76
5. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG 1996 Goodman and Gilman's, the pharmacological basis of therapeutics (Ninth Edition). McGraw Hill, New York, pp 635-636
6. Hamaguchi T, Shinkuma D, Yamanka Y, Mizuno N 1986 Bioavailability of mefenamic acid, influence of food and water intake. J Pharm Sci 75: 891-893
7. Hart FD, Huskisson EC 1984 NSAID, current status and rational therapeutics. Drugs 27: 232-252
8. Hauschke D, Steinijans VW, Diletti E 1990 A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 28: 72-78
9. Keys J, Beardon PH, Lau C, Lang CC, McDevitt DG 1992 General practitioners use of non-steroidal anti-inflammatory drugs in Tayside and Fife regions. JR Soc Med 85: 442-445
10. Lizuka Y, Tanaka K 1974 A method for evaluation of analgesic activity of drugs using heat-inflamed foot of rat. Folia Pharmacol Japan 70: 697-705
11. Sato J, Owadu E, Ito K, Niida Y, Wakamatsu A, Umetsu M 1989 Simple, rapid and sensitive reversed-phase high performance liquid Chromatographic method for the determination of mefenamic acid in plasma. J Chromatogr 493: 239-243
12. Sauter R, Steinijans VW, Diletti F., Böhm A, Shulz HU 1992 Presentation of results from bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 30: 233-256
13. Shinkuma D, Hamaguchi T, Yamanka Y, Mizuno N 1984 Correlation between dissolution rate and bioavailability of different commercial mefenamic acid capsules. Int J Pharm 21: 187-200
14. Shumaker R 1986 PKCALC, a basic interactive computer program for statistical and pharmacokinetics analysis of data. Drug Metabol Rev 17: 331-348
15. Small RE 1989 Diclofenac sodium. Clin Pharmacol 8: 545-558